Vertex: Expectations Reset With Improved Fundamentals (Rating Upgrade)
Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...
Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market
Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.70% to $511.74 Monday, on what proved to be an all-around great trading ...
Seeking Alpha4d
VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...
pharmaphorum2d
Vertex buys diabetes cell therapy rival ViaCyte for $320m
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Yahoo Finance2d
Vertex Pharmaceuticals Incorporated (VRTX)
After hours: March 25 at 7:59:50 PM EDT Loading Chart for VRTX ...
Post-Courier2d
Category: National News
The continuous wet weather over the last couple of weeks has caused a massive landslide that destroyed coffee plots, food gardens and homes at two rural village in Enga Province.